CellPort Software Achieves ISO/IEC 27001:2022 Certification for Information Security
PHILADELPHIA, PA – April 08, 2025 – CellPort Software is proud to announce its successful transition to ISO/IEC 27001:2022 certification for its Information Security Management System (ISMS). Originally certified under ISO 27001:2013 in 2023, CellPort completed this transition during its 2024 surveillance audit, reaffirming its ongoing commitment to protecting client data and ensuring system integrity.
Cloud-based platforms have become essential to modern science. As both centralized and decentralized development models evolve—especially in cell and gene therapy—secure, synchronized, and globally accessible systems are critical. Decentralized manufacturing, in particular, demands platforms that ensure real-time coordination without compromising data protection.
ISO/IEC 27001:2022 is the latest global standard for information security management. This certification confirms that CellPort’s security framework—including policies, controls, and procedures—meets rigorous, internationally recognized standards designed to address today’s evolving threats.
The certification scope includes:
- A robust ISMS protecting the technology and operations supporting CellPort.
- Company-wide coverage, including leadership, operations, QA, development, and HR.
- Ongoing alignment with the latest ISO/IEC 27001:2022 standards and continuous improvement practices.
“This is a reflection of our continued commitment to all things quality and security surrounding recording and capturing cell management processing,” said Patrick Dentinger, CEO of CellPort. “Alternative Therapy Medicinal Products pose unique manufacturing challenges—security should not be one of them. This certification ensures cell management is addressed with the rigor it demands.”
Security, traceability, and data integrity are foundational to success in advanced therapy development. ISO/IEC 27001:2022 certification demonstrates CellPort’s leadership in delivering a secure, scalable digital foundation for the future of cell and gene therapy.
About CellPort
CellPort, based in Philadelphia and lab-tested since 2014, is the all-in-one cell management platform uniquely focused on cell culture, cell banking, bioprocessing, and all upstream and downstream workflows related to cells. CellPort integrates digital capabilities like automated workflows, protocol builders, electronic batch records, and centralized communications into cell-based life sciences.
For more information and to learn about CellPort, please visit cellportsoftware.com or email contact@cellportsoftware.com.
Follow CellPort on LinkedIn: www.linkedin.com/company/cellport-software
Follow CellPort on Twitter: www.twitter.com/CellPortSW
.webp)
